TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (17)

• Endometriosis developing during tamoxifen therapy via openalex
• W1504569836 via openalex
• W1975655572 via openalex
• W2031099635 via openalex
• W2036041581 via openalex
• W2059259863 via openalex
• W2149636926 via openalex
• W2411925036 via openalex
• W2429192407 via openalex
• W2477008945 via openalex
• W2608386464 via openalex
• W2901368272 via openalex
• W3137921562 via openalex
• W4205707954 via openalex
• W6602465630 via openalex
• W61527669 via openalex
• W6715229243 via openalex

Cited by (34)

• Uterine ultrasound and endometrial biopsy in tamoxifen users 2020
• Effects of Tamoxifen and Other SERMs in the Endometrium and Follow-Up of Patients 2015
• Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients 2013
• A giant endometrial polyp with tamoxifen therapy in postmenopausal woman 2011
• Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass 2011
• Hormone Receptor Expressions and Proliferation Markers in Postmenopausal Endometrial Polyps 2005
• The Effects of Tamoxifen on the Endometrium 2004
• Adenomatous polyp--cause of postmenopausal bleeding in a breast cancer patient treated with tamoxifen. 2003
• Acute abdomen due to endometriosis in a premenopausal woman taking tamoxifen 2003
• Cytological atypia in endometrial polyps and immunostaining for p16, p53 and Ki67 2002
• Benign, Borderline, and Malignant Endometrioid Neoplasia Arising in Endometriosis in Association with Tamoxifen Therapy 2000
• Tamoxifen‐associated postmenopausal adenomyosis exhibits stromal fibrosis, glandular dilatation and epithelial metaplasias 2000
• Errors in the measurement of endometrial depth using transvaginal sonography in postmenopausal women on tamoxifen: random error is reduced using saline instillation sonography 2000
• Clear Cell Ovarian Carcinoma Following Long‐Term Tamoxifen Use 1999
• Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen 1999
• Estrogen and Progesterone Receptors of Adenomyosis in Postmenopausal Breast Cancer Patients Treated with Tamoxifen 1998
• The Demise of the D&C 1998
• II.2 Tamoxifen and benign endometrial lesions 1998
• Hormone replacement therapy following hysterectomy for endometriosis 1998
• III.1 Tamoxifen and the uterus—the hysteroscopic approach 1998
• Adenomyosis in the Broad Ligament and Tamoxifen: Report of a Case 1997
• Sonographic evaluation of the uterus in postmenopausal women receiving tamoxifen: characterization of mid-uterine abnormalities 1996
• MASSIVE ENDOMETRIAL POLYP AFTER TAMOXIFEN THERAPY 1995
• Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen 1994
• Effects of tamoxifen on uterus 1994
• Pathology of endometrium treated with tamoxifen. 1994
• Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen 1994
• Estrogen replacement therapy in women with previously treated breast cancer 1994
• Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer 1993
• Endometrial lesions in patients undergoing tamoxifen therapy 1991
• Tamoxifen and endometriosis. Case report 1990
• Hysteroscopic follow-up during Tamoxifen treatment 1990
• Tamoxifen and oestrogen replacement 1990
• Endometrial hyperplasia in an oophorectomized woman receiving tamoxifen therapy 1990

Source provenance

openalex

last seen: 2026-06-04T00:00:01.174412+00:00

unpaywall

last seen: 2026-06-02T02:00:03.124865+00:00